Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Nimer

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Leukemia|July 1, 2017
Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AMLS Kaushik, F Liu, K J Veazey, et al.
Bone Marrow Transplantation|January 11, 2005
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trialS Gupta, P Zhou, H Hassoun, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Leukemia|November 25, 2016
Loss of p300 accelerates MDS-associated leukemogenesisG Cheng, F Liu, T Asai, et al.
Blood|May 1, 1997
Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trialC H Moskowitz, P Stiff, M S Gordon, et al.
Blood|February 7, 2001
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelC H Moskowitz, S D Nimer, A D Zelenetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphomaC H Moskowitz, J R Bertino, J R Glassman, et al.
Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Leukemia|July 1, 2017
Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AMLS Kaushik, F Liu, K J Veazey, et al.
Bone Marrow Transplantation|January 11, 2005
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trialS Gupta, P Zhou, H Hassoun, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Leukemia|November 25, 2016
Loss of p300 accelerates MDS-associated leukemogenesisG Cheng, F Liu, T Asai, et al.
Blood|May 1, 1997
Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trialC H Moskowitz, P Stiff, M S Gordon, et al.
Blood|February 7, 2001
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelC H Moskowitz, S D Nimer, A D Zelenetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphomaC H Moskowitz, J R Bertino, J R Glassman, et al.
Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.
Pageof 9